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apoptosis is unclear. Interferon-mediated signaling in-
volves phosphorylation of tyrosine residues and activa-
tion of components in the Jak/Stat signaling pathway
Summary (Darnell, 1997; Haque and Williams, 1998; Liu et al., 1998;
Platanias and Fish, 1999). The phosphorylated Stat pro-
Interferon- and - inhibit the interleukin-7-mediated teins form complexes that migrate into the nucleus to
growth and survival of T and B lymphoid progenitors bind promoter sequences of target genes to regulate
via an unknown, STAT1-independent pathway. Gene their transcription (Qureshi et al., 1995; Darnell, 1997;
expression profile analysis of interferon--treated Pellegrini and Dusanter-Fourt, 1997). STAT1 appears to
be an essential component in this pathway, as miceprogenitor B cells revealed enhanced Daxx expres-
lacking STAT1 are unresponsive to interferon-inducedsion, with concomitant Daxx protein increase and nu-
upregulation of a variety of target genes and inhibitionclear body translocation. The interferon effects in-
of cell growth (Durbin et al., 1996; Meraz et al., 1996).cluded downregulation of cell cycle regulating genes
Consequently, the STAT1-deficient mice are highly sus-and cell cycle arrest, followed by Bcl-2 downregulation
ceptible to viral infection and tumor progression, al-and apoptosis. Daxx antisense oligonucleotides res-
though they have no obvious abnormalities in lymphoidcued the interferon-treated pro-B cells from growth
development. It was surprising, therefore, to find thatarrest and apoptosis in parallel with the reduction of
STAT1 is not required for the type I interferon-inducednuclear Daxx. These findings implicate the gene re-
apoptosis of B cell progenitors, thus providing evidencepressor function of Daxx in interferon-induced apopto-
for an alternative pathway of interferon-mediated cell
sis of lymphoid progenitors. signaling (Gongora et al., 2000a). Analysis of the mecha-
nism responsible for this mode of apoptosis in lymphoid
Introduction progenitors is complicated by the apparent interaction
between the IL-7 and interferon signaling pathways,
A critical checkpoint in B lymphopoiesis occurs at the which are known to share components of the Jak/Stat
transition from the pro-B to pre-B cell stage in differenti- system (Foxwell et al., 1995; Darnell, 1997). Because a
ation (Rajewsky, 1996). This progression requires the common consequence of interferon-mediated signaling
productive rearrangement of variable (V), diversity (D), is the regulation of gene transcription, we used DNA
and joining (J) region gene segments in the immunoglob- microarrays to identify alterations in the mRNA expres-
ulin heavy chain locus to create a functional variable sion profile of an IL-7-dependent pro-B cell line in re-
region exon, thereby allowing expression of  heavy sponse to type I interferons. This analysis identifies Daxx
chains together with the VpreB/5 surrogate light chain as one of the genes whose expression is upregulated
elements and the Ig/Ig signaling components of the by type I interferons and shows it to be an essential
pre-B cell receptor (Karasuyama et al., 1990). B cell regulatory element in this mode of lymphoid progenitor
development is blocked at the pro-B cell level in mice apoptosis.
and humans deficient in any one of the pre-B cell recep-
tor components (reviewed by Conley and Cooper, 1998; Results
Benschop and Cambier, 1999; Meffre et al., 2000). Pro-
B cell differentiation is also blocked in mice deficient in IFN--Induced Changes in the Gene Expression
either interleukin-7 (IL-7) or the IL-7 receptor (Namen et Profile of Pro-B Cells
al., 1988; von Freeden-Jeffry et al., 1995; Peschon et The Scid7 cell line has a pro-B cell phenotype
al., 1994). B lymphopoiesis can also be regulated by (CD19CD43IgM), grows in response to IL-7, and is
exogenous inhibitory factors (Kincade, 1994), among sensitive to interferon-mediated apoptosis (Ogawa et
which are the type I interferons,  and  (IFN- and al., 1989; Wang et al., 1995; Gongora et al., 2000a),
IFN-). Type I interferons constitutively produced by thereby providing a clonal model for its polyclonal pro-B
bone marrow macrophages can reverse the lymphopoi- cell counterparts in the bone marrow. For the DNA mi-
etic effects of IL-7 by inducing apoptosis of IL-7-respon- croarray analysis, Scid7 cells were treated with IFN-
sive lymphoid progenitors (Wang et al., 1995). Treatment for 16 hr before RNA harvesting. The 16 hr time point
of mice with type I interferon effectively blocks B cell was chosen to precede overt signs of interferon-induced
development at the pro-B cell stage (Lin et al., 1998), apoptosis, which are evident by 24 hr (Wang et al., 1995;
see Figure 1A). Before analysis of microarray data on
the gene expression profiles of treated and untreated5Correspondence: max.cooper@ccc.uab.edu
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Figure 1. Type I Interferon Effects on Scid7 Pro-B Cell Cycle and Bcl-2 Expression
(A) The DNA content of Scid7 cells, untreated or treated for 16 hr with IFN-/, was analyzed by flow cytometry as described in Experimental
Procedures.
(B) Cellular proteins from Scid7 cells, treated or untreated with IFN-/, were separated by SDS-PAGE before evaluation of Bcl-2 and actin
levels by immunoblotting with specific antibodies. In some experiments, Scid7 cells were pretreated with the Z-VAD-FMK caspase inhibitor
(100 M) for 1 hr and then were treated or untreated with IFN-/ for 24 hr.
(C) Scid7 cells were pretreated with Z-VAD-FMK at the indicated concentrations before IFN-/ treatment for 24 hr and enumeration of viable
cells in the presence of trypan blue.
Scid7 cells, the quality of synthesis reactions and hy- exhibited reduced expression (e.g., tubulin, glucoroni-
dase, and CD21). Since this profile of reduced genebridizations was confirmed (see Experimental Proce-
dures). A comparative profile analysis of relative fluores- expression occurred prior to overt signs of apoptosis,
it likely reflects an intermediate phase in the apoptoticcence intensities corresponding to gene expression
before and after IFN- treatment revealed 768 genes or program.
expressed sequence tags (EST) that exhibited a2-fold
change in expression. Increased transcript levels were
observed in the treated sample for 61% of these genes, Cell Cycle Arrest Precedes Apoptosis in the Pro-B
Cell Response to Type I Interferonswhereas decreased transcription levels were observed
for the remaining 39%. Genes found to have the greatest When the cell cycle status of the Scid7 cells was exam-
ined before and after interferon treatment, the IFN-/-alteration in expression are listed in Table 1 (complete
data sets available upon request). Many of the upregu- treated cells exhibited an obvious G0-G1 arrest and a
decrease in frequency of cells in the later cell cyclelated genes, particularly those showing the highest lev-
els of enhancement, have been previously recognized stages by 16 hr (Figure 1A). Apoptosis was manifested
at 24 hr by the presence of a large subpopulation ofas IFN-stimulated genes (ISGs). Transcripts for these
genes were often undetectable in the untreated Scid7 cells with subdiploid amounts of DNA. The reduction in
expression of cell cycle-related genes seen in the genecells (Table 1A). In contrast, a role for interferon down-
regulation has not been shown previously for most of profile analysis is thus mirrored by cell cycle arrest that
precedes apoptosis. Although lower transcript levels ofthe genes listed in Table 1B. Many of these genes are
known to participate in cell cycle regulation (e.g., Mis5, the antiapoptotic bcl-2 gene were evident at the 16 hr
time point (Table 1B), a reduction in Bcl-2 protein levelsRad51, Cdk10, and E2F1) (Gutkind, 2000). Transcript
levels for the Bcl-2 antiapoptotic protein were markedly was not evident until the 24 hr sampling interval (Figure
1B). Since reduced levels of Bcl-2 accompanied thedecreased (10-fold), but the expression of genes with
proapoptotic function, such as s-myc (Asai et al., 1994) onset of apoptosis induced by IFN-/, the Bcl-2 reduc-
tion could at least in part be attributable to protein degra-and Ste20-like protein (Graves et al., 1998), was also
reduced following IFN- treatment. In addition, other dation as a consequence of the activation of caspases
or other proteolytic enzymes. Caspase activation is agenes having no apparent effect on cell cycle or survival
IFN Inhibition of Lymphopoiesis via Daxx
729
Table 1. Scid7 Genes Regulated by Interferon- Treatment
A. Scid7 Genes Upregulated by Interferon- Treatment
Gene Name Gene Description ISG Control Fold Increase
p540ASL oligoadenylate synthetase-like protein * 83.9
GARG-16/IFI56 human glucocorticoid-attenuated regulated gene # * 68.3
ISG-15/UCRP ubiquitin cross-reactive protein # * 60.9
Mx antiviral state against the influenza virus # * 53.1
UBP43 ubiquitin-specific protease 45.6
TYMK/CDC8 thymidylate kinase homolog * 41.6
IIGP IFN-inducible GTPase # * 40.7
Irf-7 interferon regulatory factor 7 # * 37.7
BEST5 rat Best5 protein # 36.6
Ly6A/E lymphocyte differentiation antigen # 31.0
TREX1 3-5 exonuclease * 30.4
Ifi204 interferon-activated gene 204 # * 29.9
GARG-39/IFI54 glucocorticoid-attenuated response gene 39 # 29.5
Mag-1/GBP-1 IFN gamma inducible protein # * 27.6
Stat-1 signal transducer and activator of transcription-1 # 25.9
FLN29 human TRAF interacting Zn finger protein * 24.8
Ly-6C Ly-6c * 24.6
Chop10/GADD153 CHOP-10 # * 24.4
Ifi202b interferon-activated gene 202 # * 23.6
GTP2/Mg21 interferon-induced GTP binding protein # 23.5
Mg11 interferon-induced GTP binding protein # * 22.8
FcgR IgG receptor (beta-Fc-gamma-RII) # * 19.9
Evi-2 ectotropic viral integration site-2 * 18.4→Daxx Fas binding protein 17.7
IGTP GTPase 16.7
L35A 60S ribosomal protein 16.0
GBP-2 guanylate nucleotide binding protein 2 15.8
B. Scid7 Genes Downregulated by Interferon- Treatment
Gene Name Gene Description Fold Decrease
MIS5 MCM protein. DNA replication in cell cycle 16.3
nm23-M4 nucleoside diphosphate kinase 12.4
GGA2 human ADP-ribosylation factor binding protein 11.2
AES-1(Grg) aminoterminal-enhancer of split. Enhancer of split Groucho 10.4
FKBP51 FK506 binding protein 51kd. Calcineurin inhibitor. Immunophilin 10.2
Bcl-2 inhibits apoptosis 9.9
ERG2 IFN and steroid inducible protein. Embryo implantation 9.3
PoID2 DNA polymerase delta small subunit 8.3
DNA ligase I DNA metabolism 7.8
dUTPase converts dUTP into dUMP Ppi 7.6
e-IF4gamma human translation initiation factor 4G 7.5
LTB lymphotoxin  7.3
s-myc myc gene with transactivating activity. Apoptotic inducer 7.2
Rad51 mitotic and meiotic recombination and DNA repair 7.0
SCD stearoyl-CoA desaturase 6.9
CDK10 human cyclin-dependent kinase-related protein 10 6.5
GTPAAP GTPase activating protein 6.3
-tubulin cytoskeleton 6.2
IF1 protein tyrosine phosphatase 6.1
GUS -glucoronidase 5.8
Phb prohibitin. Intracellular inhibitor of proliferation 5.8
CD21 complement receptor 2 5.6
E2F1 critical determinant for the G1/S transition in the cell cycle 5.6
Cdr2 cerebellar degeneration-related autoantigen-2 5.6
SR-BI scavenger receptor class B type I. Lipoprotein receptor 5.5
Bub1b mitotic checkpoint protein kinase 5.2
Hspbp rat heat shock 70 binding protein 5.2
Ste 20-like serine-threonine kinases. Role in apoptosis 5.1
MG-160 Golgi apparatus sialoglycoprotein 5.0
ATP-citrate lyase rat lipogenic enzyme 5.0
Genes ordered according to differences in expression between treated and untreated cells. A # mark in the interferon inducible gene (ISG)
column indicates that IFNs have been found to regulate the expression of this gene in previous studies. An asterisk (*) in the control column
means that the expression of this gene could not be detected in the untreated sample, and a value was entered by software convention; the
actual fold change in this gene therefore may be underestimated. Daxx is indicated by an arrow.
general feature in most apoptotic programs, although pretreated with Z-VAD-FMK, a cell-permeable generic
caspase inhibitor (Hara et al., 1997), Bcl-2 reduction wasits importance may vary according to the model of apo-
ptosis (Green, 2000). When the Scid7 pro-B cells were still evident at 24 hr (Figure 1B), and there was no effect
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Figure 2. Analysis of the Interferon-/ Effect on Daxx Expression in Scid7 and Stat1/ Bone Marrow Cells
(A) Daxx and -actin transcripts were analyzed by RT-PCR in Scid7 cells treated with IFN-/ for different time intervals. PCR products in
agarose gels were revealed by ethidium bromide staining.
(B) Bone marrow cells from Stat1/ mice were examined before and 16 hr after treatment with IFN-/ as indicated above. PCR results on
control samples not treated with reverse transcriptase (RT) or with no template (Ø) are also shown.
on the interferon-induced cell death (Figure 1C). This Alteration of Daxx Protein Expression
by IFN-/ Treatmentfinding suggests that caspase activation is not essential
for the interferon-induced apoptosis of B lineage pro- In order to evaluate changes in the level and intracellular
localization of Daxx protein, Scid7 cells were examinedgenitors.
before and after interferon treatment by immunofluores-
cence confocal microscopy with a polyclonal anti-DaxxInterferon Induction of Daxx Expression,
antisera. A diffuse cytoplasmic distribution of Daxx wasa STAT1-Independent Effect
observed for most of the untreated cells, although someIn a search for additional clues to the mechanism of
also contained Daxx in a punctate nuclear distributionthis mode of apoptosis, we concentrated first on Scid7
pattern (Figure 3A). IFN-/ treatment induced an obvi-genes showing increased expression following type I
ous change in Daxx expression, whereby virtually all ofinterferon treatment (Table 1A). Since an important goal
the treated cells exhibited an increase of Daxx withinof these studies was to identify a STAT1-independent
the nuclear bodies (Figure 3A). Analysis of intracellularpathway of apoptosis, our attention was drawn to highly
Daxx protein levels in these experiments indicated in-expressed genes (Isg20, Sp100, and Daxx) known to be
creased expression within 8 hr after the initiation ofcomponents of nuclear bodies, because these struc-
the interferon stimulation (Figure 3B), that is, beforetures have been implicated in apoptosis (Hess and Kors-
overt cell cycle arrest (data not shown). The interferon-meyer, 1998). Moreover, the overexpression of Daxx has
induced increase in Daxx transcription was thus accom-been associated with an enhancement of Fas-mediated
panied by a prompt increase in Daxx protein and itscell death by apoptosis (Yang et al., 1997).
localization in nuclear bodies. This alteration in DaxxBecause Daxx had not been previously recognized as
expression appears to be a characteristic interferon ef-an interferon-inducible gene, we first conducted experi-
fect, as it was not seen in Scid7 cells deprived of thements to confirm the DNA microarray analysis. RT-PCR
IL-7 growth stimulus or following dexamethasone treat-assessment of the Daxx transcript levels in Scid7 cells
ment (Figure 3A), although Scid7 apoptosis is inducedtreated with IFN-/ confirmed the increased expres-
under both conditions (Wang et al., 1995; data notsion of Daxx at 16 hr. When this analysis was repeated
shown).at earlier time points, the interferon induction of Daxx
transcription was evident within the first hour of treat-
ment and persisted beyond 16 hr (Figure 2A; Table 1; IFN-/ Induction of Daxx Expression in Primary
Pro-B Cellsdata not shown). Similar results were obtained when the
Scid7 cells were pretreated with the protein synthesis Having observed that type I interferons can induce Daxx
upregulation and nuclear translocation in the Scid7 pro-inhibitor cyclohexamide. Although cyclohexamide treat-
ment itself can induce apoptosis, Daxx levels were unaf- B cell line, we examined the cellular distribution of Daxx
and the effects of type I interferon on its expression infected by 10 hr of cyclohexamide treatment in these
experiments (data not shown). These findings indicate primary B cell progenitors. B lineage subpopulations in
the bone marrow were analyzed in the initial experi-that Daxx is an early interferon-inducible gene whose
upregulation by interferon does not require new protein ments. Three subpopulations were characterized by us-
ing the B220 and CD43 markers (Hardy et al., 1991):synthesis, thereby inferring direct signaling via the type
I interferon receptor. Since we also sought a signaling B220CD43 (including most B cell progenitors),
B220CD43 (pre-B and immature B cells), andpathway that could function in the absence of STAT1,
we examined whether or not Daxx transcription could be B220highCD43 (mature B cells). Daxx-containing nuclear
spots were observed in cells belonging to all three sub-induced by interferons in STAT1-deficient mice. When
bone marrow cells from these mice were examined after populations, but cells within the pro-B cell subpopula-
tion (B220CD43) contained more Daxx-positive nu-16 hr of treatment with IFN-/, increased levels of Daxx
transcripts were detected (Figure 2B), thus indicating clear bodies than cells in the other two subpopulations
(data not shown). Since the in vivo Daxx distributionthat Daxx expression is interferon inducible via a STAT1-
independent signaling pathway. pattern may be influenced by type I interferons produced
IFN Inhibition of Lymphopoiesis via Daxx
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Figure 3. Expression and Localization of Daxx Protein in B Cell Progenitors
(A) Immunofluorescence analysis of Daxx expression by Scid7 pro-B cells before and 16 hr after treatment with IFN-/ or dexamethasone.
Staining with Daxx antibody is green, and nuclear staining with the fluorescent blue Hoechst 33258 dye is visualized by confocal microscopy.
(B) Western blot analysis of Daxx and actin levels in Scid7 cells treated or untreated with interferon for 8 and 16 hr.
(C) Analysis of interferon-/ induction of Daxx expression in B lymphocyte progenitors derived from fetal liver. B220CD43 progenitor B
cells isolated by sorting from short-term fetal liver cell cultures were recultured with or without IFN-/ in media containing IL-7 before
immunofluorescence analysis of Daxx expression by confocal microscopy.
by bone marrow macrophages (Wang et al., 1995), we 3C). Daxx upregulation and nuclear body translocation
is thus induced by type I interferons in primary B cellexamined whether or not type I interferons could induce
an increase in Daxx expression by primary B lineage progenitors as well as in the Scid7 pro-B cell line.
cells in an ex vivo environment. For these studies, a
model of B lymphopoiesis was employed, in which bone
marrow or fetal liver progenitors were grown on IL-7- Fas Expression Is Not Required for IFN-/-Mediated
Inhibition of B Lymphopoiesistransfected fibroblasts to promote efficient growth and
differentiation of B cell progenitors (Borzillo et al., 1992; Daxx was identified initially as a Fas binding protein
in an apoptotic signaling pathway differing from thatLin et al., 1998). B220 lymphoid progenitors from the
liver of normal 15 day embryos were placed in this ex involving activation of the death-inducing signaling
complex (Fas, FADD, procaspase-8) leading to cas-vivo environment for 4 days, after which their
B220CD43IgM pro-B cell progeny were purified by pase-8 activation (Yang et al., 1997). Daxx overexpres-
sion enhances Fas-induced apoptosis, although it doesfluorescence-activated cell sorting before treatment
with IFN-/ for 16 hr in IL-7 containing media. Immuno- not induce apoptosis per se and does not augment other
apoptotic stimuli (Yang et al., 1997; Torii et al., 1999).fluorescence analysis of the interferon-treated cells indi-
cated increased levels of the Daxx protein that was In an immunofluorescence analysis, we found that treat-
ment with type I interferons did not upregulate Fas inconcentrated primarily within the nuclear bodies (Figure
Immunity
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Figure 4. Interferon-/ Effects on B Lymphocyte Progenitors from Fas-Deficient Mice
(A) Analysis of interferon-induced growth inhibition. Fetal liver cells from lpr/lpr mice were cultured for 4 days in an ex vivo B lymphopoiesis
system in the presence or absence of IFN-/. Viable cells, identified by trypan blue exclusion, were then counted.
(B) Immunofluorescence analysis of Daxx distribution in B220CD43 progenitor B lineage cells derived from lpr/lpr mice and cultured with
or without interferon as described in (A).
primary B cell progenitors nor in the Scid7 pro-B cells, determine whether the antisense Daxx oligonucleotide
affected both components of the interferon response.both of which express Fas at very low levels (Mandik et
al., 1995; data not shown). However, to exclude the In these experiments, the Scid7 cells were preloaded
with the Daxx antisense or control oligos, and the cellpossibility of a Fas effect in the apoptotic pathway trig-
gered by type I interferon, we also examined the IFN- cycle status was analyzed before and after treatment
with interferon for 16 and 24 hr. In addition to the inhibi-/ response by B cell progenitors from lpr/lpr mice
that lack a functional Fas receptor (Watanabe-Fukunaga tion of Daxx protein expression, the Daxx antisense oligo
also rescued the interferon-treated pro-B cells from bothet al., 1992). When lpr/lpr fetal liver progenitors were
monitored in the ex vivo lymphopoiesis model described cell cycle arrest and the ensuing apoptosis (Figure 6).
above, their growth and survival was effectively inhibited
by IFN-/ treatment (Figure 4A) IFN-/ also induced
Daxx upregulation and nuclear body localization in the Discussion
Fas-deficient pro-B cells (Figure 4B).
This analysis indicates an important role for the Daxx
protein in the type I interferon-mediated inhibition of BDaxx Expression Is Essential for the Inhibitory Effect
of Type I Interferons lymphopoiesis. Enhanced Daxx expression was found
to be essential in this Fas-independent apoptotic pro-Given the increased level of Daxx expression observed
in the nuclear bodies of progenitor B cells treated with cess, although its role here clearly differs from that origi-
nally described, as a consequence of its interaction withinterferon, we wished to determine whether or not Daxx
is required for the ensuing apoptosis. Since the Daxx the Fas death domain (Yang et al., 1997). The present
results indicate that this interferon-triggered pathwaynull mutant is embryonically lethal (Michaelson et al.,
1999) and our DNA microarray, RT-PCR, and immunoflu- of apoptosis involves translocation of Daxx to nuclear
bodies and the related suppression of cell cycle-relatedorescence analyses indicate that Daxx is expressed in
B cell progenitors, even without treatment, we sought genes.
Nuclear bodies, also called promyelocytic leukemiato transiently reduce the expression of Daxx prior to
interferon treatment by the use of antisense (AS) Daxx (PML) oncogenic domains (PODs) (Dyck et al., 1994), Kr
bodies (del Mazo et al., 1987), or nuclear dot 10s (ND10)oligonucleotides. The antisense oligos pair with nascent
RNA, resulting in degradation by cellular RNases, as (Ascoli eand Maul, 1991), can be detected in all types
of cells. Although their protein composition, dynamics,occurs in viral infections (Praseuth et al., 1999). In these
experiments, in which sense oligos, “scrambled” non- and functions are still incompletely resolved, nearly 20
nuclear body-associated proteins have been identified.sense oligos, and water were used as controls, Scid7
cells preloaded with the different oligos grew well in the Nuclear body numbers and composition change in re-
sponse to variations in cell cycle, viral infection, andabsence of IFN-/ treatment, and their growth was
inhibited by IFN-/ treatment. In contrast, when the other conditions, indicating the functional complexity of
these cellular components (Hess and Korsmeyer, 1998;cells were pretreated with the Daxx antisense oligos,
the IFN-/ growth inhibitory effect was abolished (Fig- Everett et al., 1999). Much of the current interest in nu-
clear bodies has been stimulated by the analysis ofure 5A). As anticipated, the antisense oligo also inhibited
the interferon-induced increase in Daxx protein expres- acute promyelocytic leukemia (APL), a myeloid malig-
nancy that has been causally related to a disturbancesion (Figure 5B). Immunofluorescence analysis of these
cells confirmed that treatment with the Daxx antisense of nuclear bodies due to the presence of the PML-RAR
fusion protein created by translocation of the Pml andoligos inhibited the interferon-mediated Daxx upregula-
tion and the nuclear body localization of this protein, retinoic acid receptor (Rar) genes (Kakizuka et al., 1991).
In these leukemic cells, the nuclear body componentswhereas treatment with the control oligos or water had
no effect in these experiments (Figure 5C). are delocalized into smaller particulate structures called
microspeckles. When the APL cells are treated with all-Since, in this model system as in other apoptotic mod-
els, cell cycle arrest precedes the apoptosis induced by trans-retinoic acid, the therapeutic agent used for these
patients, the PML-RAR fusion protein is degraded, Pmlinterferons (Figure 1A) (Gutkind, 2000), we wished to
IFN Inhibition of Lymphopoiesis via Daxx
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Figure 5. Effect of Daxx Antisense Treatment on the Interferon-/ Response of Scid7 Cells
(A) Scid7 cells preloaded for 8 hr with Daxx sense (Daxx-S), antisense (Daxx-AS), or scrambled (Daxx-SC) oligonucleotides or with water (H2O)
were cultured in fresh media with or without IFN-/ for 24 additional hr before harvesting and enumeration of viable cells.
(B) Scid7 cells were cultured for 16 hr as in (A) before determination of intracellular Daxx and actin levels by Western blot analysis as indicated
in Figure 3.
(C) Scid7 cells preloaded with the oligos or water were cultured for 16 hr with or without IFN-/ before immunofluorescence analysis of Daxx
expression by confocal microscopy.
relocalizes into the nuclear bodies, and the leukemic enhanced by the interferon treatment. Moreover, inter-
feron-mediated regulation of the Pml gene has beencells undergo differentiation (Wang et al., 1998a). A re-
lated finding in Pml-deficient mice is that their myeloid shown to require STAT1 expression (Stadler et al., 1995).
Changes in Pml expression are therefore unlikely to ac-progenitors are resistant to the apoptotic effects of a
variety of stimuli, including UV light, interferons, cera- count for the STAT1-independent apoptotic response
of early B progenitors to the type I interferons, althoughmide, and Fas ligation (Wang et al., 1998b).
Isg20, Sp100, and Daxx are other protein components it could be postulated that basal levels of this protein
are required.that have been used to define nuclear bodies in humans,
and the genes for all of these proteins have now been In our analysis of B cell progenitors, we found that
Daxx expression is promptly induced by interferon treat-shown to be interferon inducible (Guldner et al., 1992;
Grotzinger et al., 1996; Gongora et al., 1997, 2000b; see ment, independently of new protein synthesis or the
presence of STAT1. The analysis of lpr/lpr mice, whichResults). High levels of transcripts for some of these
genes were detected in our DNA microarray analysis of lack Fas expression, also indicated that Fas is not re-
quired for Daxx induction and the type I interferon-medi-the interferon response prior to overt signs of apoptosis.
Daxx and Isg20 genes were among the genes for which ated apoptosis of B cell progenitors. In the progenitor
B cells treated with interferon, an accumulation of Daxxwe observed the highest levels of interferon-induced
expression. A murine EST with a short region of homol- was observed within the nuclear bodies prior to overt
apoptosis. When mouse splenocytes were treated withogy to human Sp100 was also greatly increased. Con-
versely, Pml expression, of particular interest in view Concanavalin A in another recent study, most of the B
cells died after 3 days by a mechanism involving nuclearof its demonstrated role in apoptosis, was minimally
Immunity
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Figure 6. Influence of Daxx Antisense Treatment on the Antiproliferative and Apoptotic Effects of Interferon
Scid7 pro-B cells were preloaded with oligos for Daxx, as indicated in Figure 5, before treatment with interferon and cell cycle analysis at 16
hr (A) or 24 hr (B). Percentages of cells in the different compartments of the cell cycle are indicated in the tables.
body colocalization of Pml and Daxx (Zhong et al., 2000). by the finding that pretreatment with antisense oligonu-
cleotides alleviated both the cell cycle arrest and apo-Pml, Isg20, Sp100, and other nuclear body-associated
proteins could interact with Daxx as participants in the ptosis in the interferon-stimulated Scid7 cells. In this
context, Daxx has recently been described as a repres-apoptotic program initiated by type I interferons in IL-
7-dependent lymphoid progenitors. sor of bcl-2 gene expression (Li et al., 2000b), and a
dramatic reduction of bcl-2 transcription preceded apo-Proteins localized within the nuclear bodies have been
implicated in the regulation of transcription. Nascent ptosis in the type I interferon-treated B cell progenitors
in our experiments. In addition, we have shown in previ-RNA has been reported in these structures (LaMorte et
al., 1998), although the failure to demonstrate RNA in ous studies that bcl-2 overexpression in pro-B cells se-
lectively counteracts the apoptotic effect of interferonthe nuclear bodies in a recent study suggests these may
not be sites in which transcription occurs (Boisvert et without significantly altering the growth inhibition (Wang
et al., 1995).al., 2000). Among the nuclear body components known
to be transcriptional regulators, Daxx has been shown Finding that Pml overexpression can reverse Daxx-
mediated repression of transcription, Li et al. (2000a)to mediate both basal and activated gene repression
(Hollenbach et al., 1999; Li et al., 2000a, 2000b). The proposed that Pml, itself a transcriptional activator, may
block the transcriptional repression by binding the Daxxmechanism for the Daxx-mediated repression is un-
known, but its interaction with the histone deacetylase protein and sequestering it within the nuclear body com-
plex. This attractive hypothesis does not easily explainHDAC1 suggests that histone deacetylation may be in-
volved (Li et al., 2000a). Gene repression induced by the the viability of Pml-deficient mice (Wang et al., 1998a)
or the fact that Daxx-deficient mice die early in em-physical interaction of Daxx with activating transcrip-
tional factors, such as Pax3 and Ets-1, has been also bryogenesis (Michaelson et al., 1999). It is also uncertain
whether this hypothesis could account for the type Idescribed (Hollenbach et al., 1999; Li et al., 2000b).
Our DNA microarray analysis of Scid7 cells indicated interferon effect on B cell progenitors, since the growth
inhibition and apoptosis were associated with promi-that the increase in Daxx expression induced by type I
interferons temporally correlates with a relatively broad nent nuclear body localization of Daxx. Although inter-
feron may induce enhanced expression of both Daxxrepression of gene expression that precedes the apo-
ptosis of B cell progenitors. Several of the downregu- and Pml genes, we observed that Daxx expression was
enhanced to a much greater extent than Pml expressionlated genes, including Mis5, Rad51, Cdk10, and E2F1,
are known as cell cycle regulators (Gutkind, 2000), and (17.7-fold versus 1.9-fold) in the B cell progenitors. Given
the complexity of nuclear body protein composition, acell cycle arrest was found to precede apoptosis. The
increase in Daxx protein levels occurred even earlier in delicate balance may exist between interacting nuclear
body proteins with either repressor or activating func-the interferon-treated progenitor B cells, and the possi-
bility that Daxx is involved in mediating the cell cycle tions, so that the selective perturbation of these regula-
tory elements could dictate life or death of the cell.arrest as well as subsequent apoptosis was supported
IFN Inhibition of Lymphopoiesis via Daxx
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RT-PCR AnalysisVariation in the overall composition of the nuclear body
RNA isolated from freshly harvested cells using the TRI Reagentprotein complex as a function of cell type and differentia-
(Molecular Research Center, OH) was dissolved in DEPC-treatedtion status may also contribute to the equilibrium,
water. The samples were divided into two parts: one treated withthereby accounting for the differences observed in cellu-
reverse transcriptase and the other untreated. First-strand cDNA
lar responses to interferon. As an example, whereas synthesis from RNA was carried out using poly(dT) and reverse
type I interferons induce apoptosis in pro-B cells (Wang transcriptase enzyme in the SuperScript Preamplification System
et al., 1995; Gongora et al., 2000a; see present Results), (GIBCO, Rockville, MD), following protocols supplied by the manu-
they inhibit the B cell receptor-mediated apoptosis of facturer. For evaluation of Daxx expression, forward 5- CCCATGG
CCACCGATGACAGCAT-3 and reverse 5-AGGGTTAGGGCCCmature B cells (Su and David, 1999).
GACGCCTCACT-3 primers were used. Expression of the -actinIn conclusion, these experiments reveal an unantici-
gene was examined by using forward 5-TAGACTTCGAGCAGGAGpated role for Daxx in type I interferon-mediated inhibi-
GAGATG-3 and reverse 5-CGTACTCCTGCTTGCTGATCCA-3tion of IL-7-dependent B lineage progenitors. Since type
primers. The PCR mixture was denatured in a thermal cycler at 94	CI interferons are equally inhibitory for intrathymic T cell
for 3 min, and then 25 cycles were performed, each consisting of
progenitors (Su et al., 1997; Lin et al., 1998), this STAT1- a denaturation step at 94	C for 1 min, annealing at 60	C for 2 min,
and Fas-independent pathway of apoptosis may be in- and extension at 72	C for 3 min. Dilutions of the cDNA templates
volved in the interferon-mediated inhibition of both T were performed to compare transcript levels.
and B lymphopoiesis.
Monoclonal Antibodies, Cell Sorting, Cell Cycle Analysis,Experimental Procedures
and Apoptosis Detection
FITC-labeled monoclonal antibodies to CD43, PE-labeled antibodiesMice, Cell Cultures, and Modifying Reagents
to CD45R (B220), and Cy-Chrome-labeled anti- heavy chain anti-Stat1-deficient mice of the 129 Sv/Ev background (Meraz et al.,
bodies, and an anti-Fas monoclonal antibody were obtained from1996) were obtained from Dr. Robert Schreiber (Washington Univer-
PharMingen (San Diego, CA). Cell suspensions incubated on icesity, St. Louis, MO), and the 129 Sv/Ev mice and B6.MRLlpr mice were
for 25 min with fluorochrome-labeled antibodies were washed withobtained from Jackson Laboratories. The Scid7 cell line derived from
phosphate-buffered saline containing 3% FCS and 0.02% NaN3 be-a Scid mouse was maintained as described (Ogawa et al., 1989). In
fore sorting in a Moflow flow cytometer (Cytomation, Ft. Collins,an ex vivo model of B lymphopoiesis, B cell progenitors from the
CO). For cell cycle analysis, cells suspended in ice-cold ethanolliver of 15-day-old embryos were cultured with IL-7-transfected NIH
overnight were pelleted by centrifugation and treated with RNase3T3 fibroblasts (Borzillo et al., 1992) at a concentration of 106 cells/
(Sigma) for 20 min at 37	C before incubation in the dark at roomml in RPMI 1640 medium with 5% FCS, L-glutamine, penicillin/strep-
temperature for 15 min in a solution containing propidium iodide attomycin, and 50 M -ME. IFN-, an IFN-/ combination isolated
25 g/ml and analyzed for DNA binding of propidium iodide with afrom virus-infected cultures, and control supernatants from mock-
FACScalibur flow cytometer (Becton Dickinson). Apoptotic cellsinfected cultures were purchased from Access Biomedical (San
were identified by their subdiploid DNA content or by Annexin VDiego, CA). Cyclohexamide was obtained from Calbiochem (La Jolla,
binding and exclusion of propidium iodide as described by VermesCA) and dexamethasone from Biomol (Plymouth Meeting, PA). The
et al. (1995).caspase inhibitor Z-VAD-FMK was purchased from Sigma (Saint
Louis, MO).
Western Blot Protein Analysis
Analysis of Gene Expression by DNA Microarrays Cells (5 
 107) were lysed in 500 l of lysis buffer [1% NP-40 in 150
Scid7 cells were processed before and after treatment with IFN- mM NaCl, 50 mM Tris-HCl (pH 7.5), containing 5 mM EDTA, 20 mM
to obtain poly(A) RNA by using the FastTrack 2.0 Kit (Invitrogen, iodoacetamide, 0.1% sodium azide, 20 mM -amino-caproic acid,
Carlsbad, CA). Methods for cRNA synthesis from poly(A) and addi- antipain (2 g/ml), leupeptin (1 g/ml), aprotinin (2 g/ml), chymo-
tional procedures leading to the hybridization and scanning of Gene- statin (2.5 g/ml), and pepstain (1 g/ml)]. Cell lysate proteins were
Chip arrays were conducted as recommended by the manufacturer separated by SDS-PAGE before transfer by electroblotting onto
(Affymetrix, Santa Clara, CA). Poly(A) RNA (2 g) was used for the nitrocellulose membranes that were incubated sequentially with rab-
analysis with two sets of murine GeneChips, Mu19K and Mu11K. bit anti-Bcl-2 antibodies (Santa Cruz Biotechnology, CA) and horse-
Mu19K contains probes interrogating 19,000 murine ESTs from TIGR radish peroxidase-labeled goat antibodies to rabbit Ig (Santa Cruz
(1.0 Beta), and Mu11k contains approximately 11,000 genes and Biotechnology). The Bcl-2 antigen was visualized by enhanced
ESTs from Unigene (Build 4) and 800 EST clusters from TIGR (1.0 chemiluminescence (Amersham Life Science, Airlinton Heights, IL).
Beta); approximately 20%–25% redundancy exists between the two To confirm that the lanes were loaded with equivalent amounts of
sets. A mixture of four control cRNAs for bacterial and phage genes protein, the filters were stripped following standard protocols and
was included in the hybridization solution to serve as a reference then incubated with goat anti-actin antibodies and horseradish per-
for comparison of hybridization efficiency between arrays and for oxidase-labeled donkey antibodies to goat Ig (Santa Cruz Biotech-
the relative quantification of transcript levels. The GeneChip Analy- nology) before chemiluminescence detection. The relative intensi-
sis Suite 3.3 package (Affymetrix) was used to analyze the scanned ties of the bands in X-ray films were determined using the Fluour-S
images and to process the data. Accurate orientation for scanning MultImager system (Bio-Rad, Hercules, CA) and the values ex-
of the array was achieved by addition of a biotinylated oligonucleo- pressed as the ratio of Daxx protein versus actin in cell lysates.
tide (B2) that hybridized to unique features in the four corners and
center of each chip. Comparable background autofluorescence val-
ues were found for the arrays corresponding to control (658  49) Immunocytochemistry
Cells centrifuged onto glass slides were fixed in cold methanoland IFN--treated (645  33) cells (mean fluorescence intensity 
SD). Additionally, the ratios of fluorescence intensities for the 3 and (20	C) for 20 min and were washed extensively in PBS before
blocking with 10% normal goat serum and incubation for 1 hr either5 parts of the Gapdh gene were within the normal range of variation:
control (0.85  0.02) and IFN--treated (0.82  0.04) cell samples. with rabbit polyclonal anti-Daxx antibodies (Santa Cruz Biotechnol-
ogy) or with nonimmune rabbit serum as a negative control. TheSimilar results were found in the case of the -actin gene for control
(0.96  0.02) and IFN--treated (1.27  0.03) cell samples. slides were then incubated for 45 min with an Alexa fluor 488-
conjugated goat anti-rabbit IgG (H  L) antibody. To reveal cellGene identification for some ESTs was accomplished by BLAST
search of EST sequences against existing databases, and, in other nuclei, slides were rinsed in PBS containing Hoechst 33258 at 20
g/ml for 4 min before washing in PBS. Finally, slides were mountedcases, murine ESTs were tentatively identified as homologs of mam-
malian genes by their relatively high sequence homology (80% with a coverslip in Fluoromount G (Southern Biotechnology, AL) and
stored at 20	C before examination by confocal microscopy.over a 400 bp segment).
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Antisense Oligonucleotides PML nuclear body-associated protein. J. Biol. Chem. 272, 19457–
19463.Daxx antisense (Daxx-AS), sense (Daxx-S), and scrambled (Daxx-
SC) phosphothioate oligonucleotides (Research Genetics Inc., Gongora, R., Stephan, R.P., Schreiber, R.D., and Cooper, M.D.
Huntsville, AL) were dissolved in water. Daxx-AS (5-CGGTG (2000a). Stat-1 is not essential for inhibition of B lymphopoiesis by
GCCATGGGGGTTC-3), Daxx-S (5-AATTTGAACCCCCATGGC-3), type I interferons. J. Immunol. 165, 2362–2366.
and Daxx-SC (5-CGGGTGCCTGTGGAGGTC-3) were designed to
Gongora, C., Degols, G., Espert, L., Hua, T.D., and Metchi, N. (2000b).contain the transcription initiation sequence. The Daxx-SC oligo
A unique ISRE, in the TATA-less human Isg20 promoter, confersretains the 5 CpG sequence, and the order of the other nucleotides
IRF-1 mediated responsiveness to both interferon type I and typewas randomly altered; this oligo was designed to exclude the possi-
II. Nucleic Acids Res. 28, 2333–2341.ble proliferative effect of the CpG dinucleotide (Krieg et al., 1995).
Graves, J.D., Gotoh, Y., Draves, K.E., Ambrose, D., Han, D.K., Wright,Cells were preloaded with the oligos at 280 g/ml for 8 hr before
M., Chernoff, J., Clark, E.A., and Krebs, E.G. (1998). Caspase-medi-dilution in fresh media and were treatment with interferon for 16 hr.
ated activation and induction of apoptosis by the mammalian Ste20-Viable cells were identified by trypan blue (0.4%) exclusion and were
like kinase Mst1. EMBO J. 17, 2224–2234.counted in a hematocytometer by light microscopy.
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